Alembic Pharmaceuticals receives USFDA final approval for Divalproex Sodium Delayed-Release Capsules
The investment will empower RDHL to develop a virtual diagnostic and care platform, expanding access to healthcare for underserved communities
Subscribe To Our Newsletter & Stay Updated